Australia Introduces Chlamydia Vaccine for Koalas
Australia has taken a significant step by approving and funding a vaccine aimed at protecting koalas from chlamydia, part of its broader initiative to safeguard endangered species.
Once abundant across Australia, koalas have faced dramatic declines, especially in the early 20th century when many were hunted for their fur. Although hunting is now prohibited, these animals still struggle to recover, as chlamydia remains a major threat, contributing to more than half of all koala fatalities in the wild.
This disease is typically spread through direct contact between koalas during mating or even at birth, regardless of the species. For koalas, chlamydia can lead to infertility and severe urinary tract infections, which are troublingly debilitating. Some koalas even become dehydrated and unable to forage for food.
Professor Peter Timms from Sunshine Coast University has dedicated over a decade to developing vaccines, including a single-dose option specifically designed for marsupials.
Timms expressed concern about the alarming rate at which individual koala populations are nearing “local extinction,” particularly in Queensland and New South Wales, where infection rates have surged to between 50% and 70%.
However, the new vaccine has the potential to reduce these infection rates by as much as 65%. “It offers three layers of protection: it reduces infection, halts the progression to clinical disease, and sometimes even reverses existing symptoms,” Timms elaborated.
Timms’ work has been supported by microbiologist Samuel Phillips, who noted that it took 15 years to enhance the single-dose vaccine to target three specific chlamydia proteins, along with an adjuvant.
The choice of a single-dose vaccine reflects a more conservative strategy, eliminating the need for multiple captures and treatments of koalas. “There’s no requirement to catch a koala repeatedly and bring it back to the facility,” Phillips said.
The plan is to distribute around 500 doses early next year, but they will need additional funding to ramp up production and aid roughly 60,000 wild koalas still present in Australia. Wildlife hospitals have also shown interest in the project.
Phillips estimates that there will be a requirement for at least 1,000 to 2,000 doses annually, not including efforts that focus on protecting koala populations.
The Australian government has allocated approximately $495,000 from a broader budget of $76 million aimed at koala conservation. Much of this funding will support habitat restoration efforts and the National Surveillance Program that monitors the country’s koala population.
In addition to the challenges posed by chlamydia, koalas are also threatened by significant habitat loss and deforestation, worsened by climate change.
In April, a tragic incident occurred when hundreds of koalas in areas affected by bushfires were culled by low-flying helicopters aiming to remove sick and injured animals, inadvertently leaving many healthy young koalas orphaned.
